(Q41265631)

English

Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management

scientific article published on November 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

1 reference

Europe PubMed Central

Lamotrigine-induced toxic epidermal necrolysis treated with intravenous cyclosporin: a discussion of pathogenesis and immunosuppressive management (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

toxic epidermal necrolysis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J R Sullivan

1

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

A Watson

2

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

publication date

1 November 1996

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Australasian Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

208-212

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.1996.TB01057.X

21 January 2018

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.1996.TB01057.X

21 January 2018

Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.1996.TB01057.X

21 January 2018

Toxic epidermal necrolysis treated with cyclosporin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.1996.TB01057.X

21 January 2018

The mechanisms of action of cyclosporin A in the treatment of psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.1996.TB01057.X

21 January 2018

Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.1996.TB01057.X

21 January 2018

Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.1996.TB01057.X

21 January 2018

Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.1996.TB01057.X

21 January 2018

Identifiers

10.1111/J.1440-0960.1996.TB01057.X

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41265631&oldid=2162305075"